Varicella-zoster virus gH:gL contains a structure reactive with the anti-human gamma chain of IgG near the glycosylation site

Department of Virology, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-01, Japan 1 Teijin Institute for Biomedical Research, Asahigaoka 4-3-2, Hino, Tokyo 191, Japan 2 Author for correspondence: Kimiyasu Shiraki. Fax +81 76 434 5020. e-mail kshiraki{at}toyama-mpu.ac.jp Varic...

Full description

Saved in:
Bibliographic Details
Published inJournal of general virology Vol. 82; no. 2; pp. 331 - 334
Main Authors Yokoyama, Tomonori, Ayabe, Satoko, Miyagi, Huminori, Sugano, Toru, Otsu, Akira, Sato, Hitoshi, Kageyama, Seiji, Fujii, Takao, Shiraki, Kimiyasu
Format Journal Article
LanguageEnglish
Published England Soc General Microbiol 01.02.2001
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Department of Virology, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-01, Japan 1 Teijin Institute for Biomedical Research, Asahigaoka 4-3-2, Hino, Tokyo 191, Japan 2 Author for correspondence: Kimiyasu Shiraki. Fax +81 76 434 5020. e-mail kshiraki{at}toyama-mpu.ac.jp Varicella-zoster virus (VZV) glycoproteins were purified from infected cells using monoclonal antibodies and gH:gL was found to react with antibodies to the chain of human IgG (h-IgG), whereas gE:gI and gB did not. When gH:gL was captured by concanavalin A, it lost reactivity with the anti-h-IgG chain (anti-h- -IgG). gH:gL reacted with anti-h- -IgG in an ELISA assay and gave a K d value of 2·16 x 10 -7  M in a BIAcore assay. The K d value of the human monoclonal antibody to gH (TI-57) used for the purification of gH:gL was 4·45 x 10 -10 M. Virus pretreated with anti-h-IgG was five times more resistant to neutralization with TI-57. Although the nature of the binding was not clear, gH:gL bound to anti-h- -IgG. If this interaction results from immunological similarity between gH:gL and h-IgG, it may cause immune evasion in the pathogenesis of VZV infection.
AbstractList Varicella-zoster virus (VZV) glycoproteins were purified from infected cells using monoclonal antibodies and gH:gL was found to react with antibodies to the gamma chain of human IgG (h-IgG), whereas gE:gI and gB did not. When gH:gL was captured by concanavalin A, it lost reactivity with the anti-h-IgG gamma chain (anti-h-gamma-IgG). gH:gL reacted with anti-h-gamma-IgG in an ELISA assay and gave a K:(d) value of 2.16x10(-7) M in a BIAcore assay. The K:(d) value of the human monoclonal antibody to gH (TI-57) used for the purification of gH:gL was 4.45x10(-10) M. Virus pretreated with anti-h-IgG was five times more resistant to neutralization with TI-57. Although the nature of the binding was not clear, gH:gL bound to anti-h-gamma-IgG. If this interaction results from immunological similarity between gH:gL and h-IgG, it may cause immune evasion in the pathogenesis of VZV infection.
Varicella-zoster virus (VZV) glycoproteins were purified from infected cells using monoclonal antibodies and gH:gL was found to react with antibodies to the gamma chain of human IgG (h-IgG), whereas gE:gI and gB did not. When gH:gL was captured by concanavalin A, it lost reactivity with the anti- h-IgG gamma chain (anti-h- gamma -IgG). gH:gL reacted with anti-h- gamma -IgG in an ELISA assay and gave a K sub(d) value of 2 super(.)16x10 super(-7)M in a BIAcore assay. The K sub(d) value of the human monoclonal antibody to gH (TI-57) used for the purification of gH:gL was 4 super(.)45x10 super(-10) M. Virus pretreated with anti-h-IgG was five times more resistant to neutralization with TI-57. Although the nature of the binding was not clear, gH:gL bound to anti-h- gamma -IgG. If this interaction results from immunological similarity between gH:gL and h-IgG, it may cause immune evasion in the pathogenesis of VZV infection.
Varicella-zoster virus (VZV) glycoproteins were purified from infected cells using monoclonal antibodies and gH:gL was found to react with antibodies to the γ chain of human IgG (h-IgG), whereas gE:gI and gB did not. When gH:gL was captured by concanavalin A, it lost reactivity with the anti-h-IgG γ chain (anti-h-γ-IgG). gH:gL reacted with anti-h-γ-IgG in an ELISA assay and gave a K d value of 2·16×10 −7  M in a BIAcore assay. The K d value of the human monoclonal antibody to gH (TI-57) used for the purification of gH:gL was 4·45×10 −10 M. Virus pretreated with anti-h-IgG was five times more resistant to neutralization with TI-57. Although the nature of the binding was not clear, gH:gL bound to anti-h-γ-IgG. If this interaction results from immunological similarity between gH:gL and h-IgG, it may cause immune evasion in the pathogenesis of VZV infection.
Department of Virology, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-01, Japan 1 Teijin Institute for Biomedical Research, Asahigaoka 4-3-2, Hino, Tokyo 191, Japan 2 Author for correspondence: Kimiyasu Shiraki. Fax +81 76 434 5020. e-mail kshiraki{at}toyama-mpu.ac.jp Varicella-zoster virus (VZV) glycoproteins were purified from infected cells using monoclonal antibodies and gH:gL was found to react with antibodies to the chain of human IgG (h-IgG), whereas gE:gI and gB did not. When gH:gL was captured by concanavalin A, it lost reactivity with the anti-h-IgG chain (anti-h- -IgG). gH:gL reacted with anti-h- -IgG in an ELISA assay and gave a K d value of 2·16 x 10 -7  M in a BIAcore assay. The K d value of the human monoclonal antibody to gH (TI-57) used for the purification of gH:gL was 4·45 x 10 -10 M. Virus pretreated with anti-h-IgG was five times more resistant to neutralization with TI-57. Although the nature of the binding was not clear, gH:gL bound to anti-h- -IgG. If this interaction results from immunological similarity between gH:gL and h-IgG, it may cause immune evasion in the pathogenesis of VZV infection.
Author Sugano, Toru
Fujii, Takao
Ayabe, Satoko
Otsu, Akira
Shiraki, Kimiyasu
Sato, Hitoshi
Yokoyama, Tomonori
Kageyama, Seiji
Miyagi, Huminori
Author_xml – sequence: 1
  fullname: Yokoyama, Tomonori
– sequence: 2
  fullname: Ayabe, Satoko
– sequence: 3
  fullname: Miyagi, Huminori
– sequence: 4
  fullname: Sugano, Toru
– sequence: 5
  fullname: Otsu, Akira
– sequence: 6
  fullname: Sato, Hitoshi
– sequence: 7
  fullname: Kageyama, Seiji
– sequence: 8
  fullname: Fujii, Takao
– sequence: 9
  fullname: Shiraki, Kimiyasu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11161270$$D View this record in MEDLINE/PubMed
BookMark eNqFkUFv1DAQhS1URLeFP8AB-QQnw4wTJxtuqIK20kpcgKvlOJPEKLGL7bRaJP472e6qHDnNYb73RvPeBTvzwRNjrxHeIzTNBwApBRZYi60UUhQFPmMbLCsl5Lo-Y5sn4JxdpPQTAMtS1S_YOSJWKGvYsD8_THSWpsmI3yFlivzexSXx4ebjsOM2-GycT9zwlONi8xKJRzI2u3viDy6PPI_Ejc9OjMtsPB_MPBtux1XFQ89vh2vuycRHbJj2NqT9ZLILnieX6SV73psp0avTvGTfv3z-dnUjdl-vb68-7YQtocqCuqaRBjpsVd-BJaxk3xWy7Q00tpUEsDVKblusGiyLtu8IVIFtA6Vq2qY0xSV7e_S9i-HXQinr2aXHrz2FJekaKoUg6_-CWNdKFQpWUB5BG0NKkXp9F91s4l4j6EM7-hC-PoSvt1JLvbazit6c3Jd2pu6f5FTHCrw7AqMbxgcXSQ_kZ7feaF3QazNPVn8BRG2bXA
CitedBy_id crossref_primary_10_1128_JVI_78_6_2884_2896_2004
crossref_primary_10_1128_JVI_02561_12
crossref_primary_10_1128_JVI_02097_08
crossref_primary_10_18632_oncotarget_7688
crossref_primary_10_1002_jmr_598
crossref_primary_10_1038_nbt1363
crossref_primary_10_1002_jmv_20838
crossref_primary_10_1016_j_biortech_2016_02_068
crossref_primary_10_1128_JVI_00269_18
crossref_primary_10_1016_j_bios_2014_09_025
Cites_doi 10.1086/315336
10.1128/JVI.66.1.341-348.1992
10.1016/0042-6822(83)90175-7
10.1128/JVI.63.8.3435-3443.1989
10.1006/viro.1994.1007
10.1146/annurev.mi.44.100190.000423
10.1016/0042-6822(86)90124-8
10.1002/eji.1830170309
10.1099/0022-1317-61-2-255
10.1006/viro.1995.1359
10.1099/0022-1317-61-2-271
10.1099/0022-1317-72-9-2065
10.1016/S0264-410X(98)00035-8
10.1006/viro.1994.1145
10.1007/s007050050243
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7U9
H94
7X8
DOI 10.1099/0022-1317-82-2-331
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
AIDS and Cancer Research Abstracts
CrossRef

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1465-2099
EndPage 334
ExternalDocumentID 10_1099_0022_1317_82_2_331
11161270
vir82_2_331
Genre Journal Article
GroupedDBID -
08R
186
2WC
39C
3O-
53G
55
5GY
5RE
ABFLS
ABUFD
ACBTR
ADACO
ADBBV
ADBIT
ADCOW
AEILP
AENEX
AFFNX
AFWKH
AGCAB
AGCDD
ALMA_UNASSIGNED_HOLDINGS
BAWUL
C1A
CJ0
CS3
DIK
DL
DU5
E3Z
EBS
EJD
F5P
FRP
GJ
GX1
H13
IH2
K-O
KM
L7B
O0-
OK1
P2P
RGM
UQL
VH1
WH7
WOQ
X
X7M
XHC
Y6R
ZGI
---
-~X
.55
.GJ
18M
4.4
AAJMC
ABDNZ
ACGFO
ACPEE
ACYGS
ADCDP
AI.
AJKYU
CGR
CUY
CVF
ECM
EIF
NPM
OHT
TR2
W8F
WHG
YKV
YSK
~KM
AAYXX
CITATION
7T5
7U9
H94
7X8
ID FETCH-LOGICAL-c406t-ed992a0d1b5fd0ce162fd32bfa09cb2e008a528b169143bfde0531b90459b94a3
ISSN 0022-1317
IngestDate Fri Aug 16 21:59:19 EDT 2024
Fri Aug 16 22:31:53 EDT 2024
Fri Aug 23 01:31:47 EDT 2024
Wed Oct 16 00:46:42 EDT 2024
Tue Jan 05 21:43:57 EST 2021
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c406t-ed992a0d1b5fd0ce162fd32bfa09cb2e008a528b169143bfde0531b90459b94a3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://doi.org/10.1099/0022-1317-82-2-331
PMID 11161270
PQID 17755350
PQPubID 23462
PageCount 4
ParticipantIDs proquest_miscellaneous_70651027
proquest_miscellaneous_17755350
crossref_primary_10_1099_0022_1317_82_2_331
pubmed_primary_11161270
highwire_genmicrobio_vir82_2_331
PublicationCentury 2000
PublicationDate 2001-02-01
PublicationDateYYYYMMDD 2001-02-01
PublicationDate_xml – month: 02
  year: 2001
  text: 2001-02-01
  day: 01
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of general virology
PublicationTitleAlternate J Gen Virol
PublicationYear 2001
Publisher Soc General Microbiol
Publisher_xml – name: Soc General Microbiol
References Shiraki (R11) 1982; 61
Sato (R10) 1998; 16
Grose (R5) 1990; 44
Shiraki (R12) 1982; 61
Duus (R1) 1995; 210
Matsui (R7) 1994; 198
Shiraki (R13) 1997; 142
Sugano (R15) 1991; 72
Forghani (R2) 1994; 199
Fuller (R4) 1989; 63
Okuno (R9) 1983; 129
Sugano (R14) 1987; 17
Montalvo (R8) 1986; 149
Forrester (R3) 1992; 66
Kamiyama (R6) 2000; 181
References_xml – volume: 181
  start-page: 1158
  year: 2000
  ident: R6
  article-title: Novel immunogenicity of Oka varicella vaccine vector expressing hepatitis B surface antigen
  publication-title: Journal of Infectious Diseases
  doi: 10.1086/315336
  contributor:
    fullname: Kamiyama
– volume: 66
  start-page: 341
  year: 1992
  ident: R3
  article-title: Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted
  publication-title: Journal of Virology
  doi: 10.1128/JVI.66.1.341-348.1992
  contributor:
    fullname: Forrester
– volume: 129
  start-page: 357
  year: 1983
  ident: R9
  article-title: Synthesis and processing of glycoproteins of varicella-zoster virus (VZV) as studied with monoclonal antibodies to VZV antigens
  publication-title: Virology
  doi: 10.1016/0042-6822(83)90175-7
  contributor:
    fullname: Okuno
– volume: 63
  start-page: 3435
  year: 1989
  ident: R4
  article-title: Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration
  publication-title: Journal of Virology
  doi: 10.1128/JVI.63.8.3435-3443.1989
  contributor:
    fullname: Fuller
– volume: 198
  start-page: 50
  year: 1994
  ident: R7
  article-title: Functional roles of terminal glycomoieties in varicella-zoster virus infection
  publication-title: Virology
  doi: 10.1006/viro.1994.1007
  contributor:
    fullname: Matsui
– volume: 44
  start-page: 59
  year: 1990
  ident: R5
  article-title: Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking
  publication-title: Annual Review of Microbiology
  doi: 10.1146/annurev.mi.44.100190.000423
  contributor:
    fullname: Grose
– volume: 149
  start-page: 230
  year: 1986
  ident: R8
  article-title: Neutralization of epitope of varicella-zoster virus on native viral glycoproteins gp118 (VZV glycoprotein gpIII)
  publication-title: Virology
  doi: 10.1016/0042-6822(86)90124-8
  contributor:
    fullname: Montalvo
– volume: 17
  start-page: 359
  year: 1987
  ident: R14
  article-title: Hybridomas producing human monoclonal antibodies against varicella-zoster virus
  publication-title: European Journal of Immunology
  doi: 10.1002/eji.1830170309
  contributor:
    fullname: Sugano
– volume: 61
  start-page: 255
  year: 1982
  ident: R12
  article-title: Polypeptides of varicella-zoster virus (VZV) and immunological relationship of VZV and herpes simplex virus (HSV)
  publication-title: Journal of General Virology
  doi: 10.1099/0022-1317-61-2-255
  contributor:
    fullname: Shiraki
– volume: 210
  start-page: 429
  year: 1995
  ident: R1
  article-title: Cell surface expression and fusion by the varicella-zoster virus gH: gL glycoprotein complex: analysis by laser scanning confocal microscopy
  publication-title: Virology
  doi: 10.1006/viro.1995.1359
  contributor:
    fullname: Duus
– volume: 61
  start-page: 271
  year: 1982
  ident: R11
  article-title: Virus particles and glycoproteins excreted from cultured cells infected with varicella-zoster virus (VZV)
  publication-title: Journal of General Virology
  doi: 10.1099/0022-1317-61-2-271
  contributor:
    fullname: Shiraki
– volume: 72
  start-page: 2065
  year: 1991
  ident: R15
  article-title: A human monoclonal antibody against varicella-zoster virus glycoprotein III
  publication-title: Journal of General Virology
  doi: 10.1099/0022-1317-72-9-2065
  contributor:
    fullname: Sugano
– volume: 16
  start-page: 1263
  year: 1998
  ident: R10
  article-title: Immune response to varicella-zoster virus glycoproteins in guinea pigs infected with Oka varicella vaccine
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(98)00035-8
  contributor:
    fullname: Sato
– volume: 199
  start-page: 458
  year: 1994
  ident: R2
  article-title: Neutralization epitope of the varicella-zoster virus gH: gL glycoprotein
  publication-title: Virology
  doi: 10.1006/viro.1994.1145
  contributor:
    fullname: Forghani
– volume: 142
  start-page: 2295
  year: 1997
  ident: R13
  article-title: Functions of purified gB, gE: gl, and gH:gL, and their sialyl residues in varicella-zoster virus infection
  publication-title: Archives of Virology
  doi: 10.1007/s007050050243
  contributor:
    fullname: Shiraki
SSID ssj0014457
Score 1.7239501
Snippet Department of Virology, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-01, Japan 1 Teijin Institute for Biomedical Research,...
Varicella-zoster virus (VZV) glycoproteins were purified from infected cells using monoclonal antibodies and gH:gL was found to react with antibodies to the...
Varicella-zoster virus (VZV) glycoproteins were purified from infected cells using monoclonal antibodies and gH:gL was found to react with antibodies to the γ...
SourceID proquest
crossref
pubmed
highwire
SourceType Aggregation Database
Index Database
Publisher
StartPage 331
SubjectTerms Antibodies, Monoclonal - immunology
Biosensing Techniques
Concanavalin A - immunology
Enzyme-Linked Immunosorbent Assay
Glycoproteins - chemistry
Glycoproteins - immunology
Glycosylation
Herpesvirus 3, Human - chemistry
Herpesvirus 3, Human - immunology
Humans
Immunoglobulin G - chemistry
Immunoglobulin G - immunology
Immunoglobulin Heavy Chains - chemistry
Immunoglobulin Heavy Chains - immunology
Immunoglobulin kappa-Chains - chemistry
Immunoglobulin kappa-Chains - immunology
Immunoglobulin lambda-Chains - chemistry
Immunoglobulin lambda-Chains - immunology
Neutralization Tests
varicella-zoster virus
Viral Proteins - chemistry
Viral Proteins - immunology
Title Varicella-zoster virus gH:gL contains a structure reactive with the anti-human gamma chain of IgG near the glycosylation site
URI http://vir.sgmjournals.org/cgi/content/abstract/82/2/331
https://www.ncbi.nlm.nih.gov/pubmed/11161270
https://search.proquest.com/docview/17755350
https://search.proquest.com/docview/70651027
Volume 82
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiQuiDddXj5wiwKJ8zQ3hGALWiEkuqicIjtxshGkWbXJSlmJ_8BPZsZO0naXSsAlqpKpHc332Rnb8yDkReZlPpfKsbknU9vPcwFDKnZsKYUbZiqK3Ex7-X4KZyf-x0WwmEx-bXkttY18mV78Ma7kf1CFe4ArRsn-A7Jjo3ADfgO-cAWE4fpXGH8VmBIIgLQvMFZjZZ2Xq3ZtFTNooDjWbugCXWCEZdLE4mEBGIl6iut3YE_x-KApbVOrrxBVJTAYuNRW5IfiyFpiph8UK350ab3ujO-chYfOewzbwmSyxpfZ2bP_Vn-vO1Fpa3Veg5LqVTnyrRPSbIaLBsRGGpSdKExd7bYqt__wpS2ErhoOTa3anb0Ld3B3zrdjCVzPRG8O83HMtnj3ubHY1vzah3ddmffBztWOkn1zNiwbmH1JGFR_VmkmwPwe4on75hs4eiYOj66R6yziATqJHi1GpyFYfQbRkH8eO-rDsKD7V1c7x4S0fXO7Vs-QiXr_qkZbN_Pb5FaPHn1jOHaHTNTyLrlhCpV298jPy0yjmmm0mL0ujunAMyroyDM68IwizygQiG54RjXPqOYZrXMKPKPIMy22wzOKPLtPTt6_m7-d2X3hDjsF-7CxVcY5E07myiDPnFS5Icszj8lcODyVTIHdKQIWS0zU5Hsyz7A-iSs5LC-45L7wHpCDZb1UjwgVoRIqTyOexcqPPRHn8IUWUZhiKYQwjafEGhSbnJn8LInxq-AJIpIgIknMEpYAIlNCB90nMBiq0iQ7S0BnG5HnAyYJzLRatUtVt-vEjaIg8AJnvwS6DIDBHk3JQwPm5pV6HhzuffKY3NyMkCfkAOBST8HebeQzTcHfwfqrGQ
link.rule.ids 315,786,790,27955,27956
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Varicella-zoster+virus+gH%3AgL+contains+a+structure+reactive+with+the+anti-human+gamma+chain+of+IgG+near+the+glycosylation+site&rft.jtitle=Journal+of+general+virology&rft.au=Yokoyama%2C+Tomonori&rft.au=Ayabe%2C+Satoko&rft.au=Miyagi%2C+Huminori&rft.au=Sugano%2C+Toru&rft.date=2001-02-01&rft.issn=0022-1317&rft.volume=82&rft.issue=Pt+2&rft.spage=331&rft_id=info:doi/10.1099%2F0022-1317-82-2-331&rft_id=info%3Apmid%2F11161270&rft.externalDocID=11161270
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1317&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1317&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1317&client=summon